{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69639-101",
      "generic_name": "Netupitant and Palonosetron",
      "labeler_name": "Helsinn Therapeutics (U.S.), Inc.",
      "brand_name": "AKYNZEO",
      "active_ingredients": [
        {
          "name": "NETUPITANT",
          "strength": "300 mg/1"
        },
        {
          "name": "PALONOSETRON",
          "strength": ".5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69639-101-01",
          "description": "1 BLISTER PACK in 1 CARTON (69639-101-01)  / 1 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20141013",
          "sample": false
        },
        {
          "package_ndc": "69639-101-04",
          "description": "2 BLISTER PACK in 1 CARTON (69639-101-04)  / 2 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20141013",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Helsinn Therapeutics (U.S.), Inc."
        ],
        "rxcui": [
          "1552343",
          "1552349",
          "2044429",
          "2044431",
          "2374366",
          "2374368"
        ],
        "spl_set_id": [
          "8e47618e-af46-4d82-94e8-1507c042252d"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0369639101046"
        ],
        "nui": [
          "N0000175817",
          "N0000175818",
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_moa": [
          "Serotonin 3 Receptor Antagonists [MoA]",
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Serotonin-3 Receptor Antagonist [EPC]",
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "5D06587D6R",
          "7732P08TIR",
          "23310D4I19",
          "T672P80L2S"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "CAPSULE",
      "spl_id": "c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20141013",
      "product_id": "69639-101_c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1",
      "application_number": "NDA205718",
      "brand_name_base": "AKYNZEO",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Neurokinin 1 Antagonists [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Serotonin 3 Receptor Antagonists [MoA]",
        "Serotonin-3 Receptor Antagonist [EPC]",
        "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
      ]
    }
  ]
}